Research

IRB Barcelona’s research purpose is to address fundamental biological questions in order to provide groundbreaking solutions to unmet medical needs. Our institute is organised around three major research challenges, namely Cancer Science, Aging and Metabolism, and Mechanisms of Disease, with the aim to decipher why diseases develop and find new ways to diagnose, prevent and treat them.
At IRB Barcelona, 400 outstanding scientists from diverse disciplines and technical support staff come together to develop knowledge that will ultimately allow society to overcome these challenges.

Research Structure Chemical and Structural Biology Computational Biology Invertebrate Models of Disease Cell Pathophysiology Preclinical models of Cancer Preclinical models of Disease Aging and Metabolism Cancer Science Mechanisms of Disease

Core Facilities & Services

Research groups:

Aging and Metabolism

Description:

Our aging society brings with it significant challenges with respect to health. The Aging and Metabolism Programme focuses on deciphering the mechanisms underlying the aging process and associated disruptions in metabolic pathways. Research efforts into these fields seek to develop precision therapies for aging-related diseases, putting an emphasis on multi-morbidities, with the purpose to ensure healthy aging.

Cancer Science

Description:

The Cancer Science Programme strives to unravel the molecular, cellular and physiological processes that lead to cancer and the most deadly complication of this disease, namely metastasis. Detailed studies of the mechanisms responsible for malignant transformation and of the relationship between stem cells and cancer will improve the chances of finding solutions and make a significant difference to patients’ lives.

Programmes

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros.

Core Facilities & Services

Research groups:

Mechanisms of Disease

Description:

Human diseases are characterized by impairments in cellular and molecular functions. The Mechanisms of Disease Programme is devoted to understanding the correct function of the cell and thus identify the underlying bases of pathological conditions. The programme applies a highly interdisciplinary approach, involving genetics, proteomics and animal models of human disease, to provide answers to fundamental questions in the life sciences.

Research groups:

Aging and Metabolism

Description:

Our aging society brings with it significant challenges with respect to health. The Aging and Metabolism Programme focuses on deciphering the mechanisms underlying the aging process and associated disruptions in metabolic pathways. Research efforts into these fields seek to develop precision therapies for aging-related diseases, putting an emphasis on multi-morbidities, with the purpose to ensure healthy aging.

Research groups:

External Affiliated Group Leader:

  • Oscar Yanes, Centre for Omic Sciences (COS). CIBERDEM.

Cancer Science

Description:

The Cancer Science Programme strives to unravel the molecular, cellular and physiological processes that lead to cancer and the most deadly complication of this disease, namely metastasis. Detailed studies of the mechanisms responsible for malignant transformation and of the relationship between stem cells and cancer will improve the chances of finding solutions and make a significant difference to patients’ lives.

Research groups:

External Affiliated Group Leader:

  • Jaume Mora, Developmental Cancer. Sant Joan de Déu Research Foundation.

Research Nodes

Biomedical problems are complex and must be tackled following a strategy that combines scientific disciplines with the aim to advance towards a common goal: a deeper understanding of pathology that will lead to improved therapeutic approaches, moving basic research to clinical stage testing. To facilitate interdisciplinary collaboration and knowledge sharing, our researchers are organised into six integrative research nodes.

Chair: Modesto Orozco

Research Nodes secretary: Eva Poca

Chemical and Structural Biology

Description:

Researchers in this node address a common interest, namely understanding biomedicine at the deepest molecular level. Each laboratory contributes a different approach, including the ability to design and synthesise new bioactive compounds, to study and unravel the molecular interactions taking place at protein surfaces, and to elucidate the structure of biomacromolecules and other structurally complex systems.

Computational Biology

Description:

The Computational Biology Node brings together research groups that develop data-analytical and theoretical methods to study fundamental biological processes and explore novel therapeutic strategies. Indeed, the interests of the node cover a broad scientific spectrum: from the modelling and simulation of the dynamic properties macromolecular interactions to chemoinformatics, cancer genomics and systems medicine.

Invertebrate Models of Disease

Description:

Basic research carried out in invertebrate model organisms has often provided the first glimpse into the mechanism of action of genes and proteins involved in human diseases. The Invertebrate Models of Disease Node includes four laboratories that use the fruit fly Drosophila melanogaster to address fundamental questions in cell and developmental biology, as well as to study key aspects of human diseases, including cancer.

Cell Pathophysiology

Description:

The Cell Pathophysiology Node brings together groups devoted studying the basic molecular mechanisms that regulate normal cell function and their alteration in disease. The node uses a variety of cellular models—from yeast to human cells—and experimental approaches, including genetics and “omics” methodologies.

Preclinical Models of Cancer

Description:

Cancer is the second cause of death in industrialised countries. Despite significant advances in our understanding of the disease, many types of cancer remain incurable. The Preclinical Models of Cancer Node aims to identify and characterise the cellular and molecular mechanisms that underlie tumourigenesis, with a special emphasis on metastasis. To this end, the node uses its strong background in basic biology to drive the development of novel anti-tumour therapies in clinical practice. An exciting group of multidisciplinary scientists are using state-of-the-art approaches such as mouse models of cancer, patient-derived samples, omics, epigenetics, immunology, organoid research, and computational biology, among others, to achieve these goals.

Preclinical Models of Disease

Description:

The leitmotif of the Preclinical Models of Disease Node is to unravel the normal mechanisms operating in physiology and those underlying disease. To this end researchers use a variety of murine models and a wide range of experimental approaches, including physiological, biochemical, genetic and “omics” methodologies. The main translational goal of this node is the identification of therapeutic targets.

Core Facilities & Services

Scientists at IRB Barcelona are supported by an extensive range of Core Facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible as well as, when the availability of resources allows it, offering their expertise to other external users.

Head of Core Facilities: Goretti Mallorqui

Core Facilities and Services Officer: Marc Boix

Senior Research Officer: Jesús García

IRB Barcelona Equipment open to external users:

Whitley H35 Hypoxia Cabin

Contact: marc.boix@irbbarcelona.org

Interdisciplinary initiatives

IRB Barcelona's partnerships with organisations in areas of mutual interest and expertise aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine

Selected IRB Barcelona publications

Luis Martínez-Crespo, Jia Liang Sun-Wang, Andres Felipe Sierra, Gemma Aragay, Ekaitz Errasti-Murugarren, Paola Bartoccioni, Manuel Palacín, P.Ballester
Chem , 6 (11), 3054-3070 (2020)
Silvia Tognetti, Javier Jiménez, Matteo Viganò, Alba Duch, Ethel Queralt, Eulàlia de Nadal, Francesc Posas
PNAS, 117 (16), 8924-8933 (2020)
Lidia Mateo , Miquel Duran-Frigola , Albert Gris-Oliver , Marta Palafox , Maurizio Scaltriti , Pedram Razavi , Sarat Chandarlapaty , Joaquin Arribas , Meritxell Bellet , Violeta Serra , Patrick Aloy
Genome Med, 12 (1), 78 (2020)
Rosa Fernández , Marina Marcet-Houben , Fabrice Legeai , Gautier Richard , Stéphanie Robin , Valentin Wucher , Cinta Pegueroles , Toni Gabaldón , Denis Tagu
Mol Biol Evol, 37 (9), 2601-2615 (2020)
Uciel Chorostecki, Manuel Molina, Leszek P Pryszcz, Toni Gabaldón
Nucleic Acids Res, 48 (W1), W553-W557 (2020)
Sonia Ciudad , Eduard Puig , Thomas Botzanowski , Moeen Meigooni , Andres S Arango , Jimmy Do , Maxim Mayzel , Mariam Bayoumi , Stéphane Chaignepain , Giovanni Maglia , Sarah Cianferani , Vladislav Orekhov , Emad Tajkhorshid , Benjamin Bardiaux 0, Natàlia Carulla
Nat Commun, 11 (1), 3014 (2020)
Albert Cabré, Sergi Rafael, Giuseppe Sciortino, Gregori Ujaque, Xavier Verdaguer, Agustí Lledós, Antoni Riera
Angew Chem Int Edit, 59 (19), 7521-7527 (2020)
Fabian Zimmermann, Marina Serna, Artur Ezquerra, Rafael Fernandez-Leiro, Oscar Llorca, Jens Luders
Sci Adv, 6 (51), eabe0894 (2020)
Marina Salvadores, Francisco Fuster-Tormo, Fran Supek
Sci Adv, 6 (27), eaba1862 (2020)
Cian J Lynch , Raquel Bernad , Ana Martínez-Val , Marta N Shahbazi , Sandrina Nóbrega-Pereira , Isabel Calvo , Carmen Blanco-Aparicio , Carolina Tarantino , Elena Garreta , Laia Richart-Ginés , Noelia Alcazar , Osvaldo Graña-Castro 0, Gonzalo Gómez-Lopez 0, Irene Aksoy , Maribel Muñoz-Martín , Sonia Martinez , Sagrario Ortega , Susana Prieto , Elisabeth Simboeck , Alain Camasses , Camille Stephan-Otto Attolini , Agustin F Fernandez , Marta I Sierra , Mario F Fraga , Joaquin Pastor , Daniel
Nat Cell Biol, 22 (10), 1223-1238 (2020)
David Mas-Ponte, Fran Supek
Nat Genet, 52 (9), 958 (2020)
Miquel Duran-Frigola, Eduardo Pauls, Oriol Guitart-Pla, Martino Bertoni, Víctor Alcalde, David Amat, Teresa Juan-Blanco, Patrick Aloy
Nat Biotechnol, 38 (9), 1087 (2020)
Rosa Fernández, Toni Gabaldón
Nat Ecol Ev, 4 (4), 524-5 (2020)
Alexandros A Pittis, Valerie Goh , Alberto Cebrian-Serrano, Jennifer Wettmarshausen, Fabiana Perocchi, Toni Gabaldón
Nat Commun, 11 (1), 4031 (2020)
Julian Vosseberg, Jolien J E van Hooff, Marina Marcet-Houben, Anne van Vlimmeren, Leny M van Wijk, Toni Gabaldón, Berend Snel
Nat Ecol Ev, 5 (1), 92-10 (2021)